DUBLIN–(BUSINESS WIRE)–The “Regulatory Report: Changes Expected to France’s Regulation of CBD” report has been added to ResearchAndMarkets.com’s offering.
Regulation, and the interpretation of existing rules, of cannabis in all its forms is a recurring subject in France, and one that is set to continue following the Court of Justice of the European Union (CJEU)’s recent decision in the Kanavape case. Aside from changes relating to that, there are a number of other proposals relating to France’s medical cannabis regime. This report provides a detailed overview of all current and possible future regulation.
The CJEU’s recent ruling is likely to have deep consequences for Europe’s CBD industry, and while France has not released an interpretation yet, the government will have no choice but to adapt to the ruling.
This report will provide you with everything you need to know about France’s regulatory framework for CBD and cannabis, from processing and cultivation of hemp to the country’s medical and recreational regimes.
Key Topics Covered:
- Executive Summary
- Hemp Plant
- Extracts as a Finished Product
- Finished Products Containing CBD and Extracts
- Import and Export Requirements
- Enforcement Actions
- Medical Cannabis
- Recreational Cannabis
- Relevant Laws
- Relevant Bodies
For more information about this report visit https://www.researchandmarkets.com/r/l7pl7y
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900